Navigation Links
The Female Health Company to Present at Rodman & Renshaw's Annual Global Investment Conference on Wednesday, September 15, 2010
Date:9/3/2010

CHICAGO, Sept. 3 /PRNewswire/ -- The Female Health Company (Nasdaq: FHCO), which manufactures and markets the FC2 Female Condom®, today announced that the Company's CEO, O.B. Parrish, and its CFO, Donna Felch, are scheduled to make a presentation at Rodman & Renshaw's Global Investment Conference at 12:05 p.m. on Wednesday, September 15, 2010, in the Hubbard Salon, 5th floor.

The Conference will be held September 12-15, 2010 at the New York Palace Hotel in New York City.  Additional information on the Conference is available on the Internet at http://www.rodm.com/conferences?category&id=51

About Rodman & Renshaw

Rodman & Renshaw is a full-service investment banking firm that is dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies.  The firm also provides research, sales and trading services to institutional investor clients that focus on such companies.

Through its life sciences investment banking team, Rodman & Renshaw provides a broad range of investment banking services to biotechnology, specialty pharmaceutical, medical device and other companies operating in the life science space.  The team consists of seasoned professionals, many of whom have PhDs or other advanced medical or scientific degrees.  Their experience and expertise enable the firm to deliver the specialized advice and differentiated services its clients demand.

Additional information on Rodman & Renshaw is available on the Internet at www.rodmanandrenshaw.com

About The Female Health Company

The Female Health Company, based in Chicago, Illinois, manufactures and ma
'/>"/>

SOURCE The Female Health Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Bionovo to Present on Novel Female-Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society
2. Frost & Sullivan: Female Cancer Patients More Willing to Use Implantable Infusion Pumps Than Males
3. The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance
4. The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference
5. New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets
6. Reportlinker Adds Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
7. Uckele Health & Nutrition Ranks on the 2010 Inc. 5000 List
8. maxIT Healthcare Named to Inc. 5000 List
9. BioFortis and Catholic Health Initiatives Center for Translational Research Announce Biorepository Information Technology Strategic Partnership to Drive Progress in Personalized Medicine
10. Back To School: Staying Healthy at School is as Easy as Learning Your ABCs
11. Healthcare Network Helps Fund Scholarships Totaling $15,000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2012)... First tenant moves in Stevenage Bioscience Catalyst ... to announce that it is now open for business. In ... , which has taken space in the Incubator building. SBC ... one - discussions with a range of interesting tenants are ... and events focused on rejuvenation of the UK biosciences sector. ...
(Date:2/8/2012)...  Neuralstem, Inc. (NYSE Amex: CUR ... will present at the 14th Annual BIO CEO ... on Monday, February 13, at 3:00 p.m. EST. ... update on the company,s ongoing clinical trials in ... (Logo:  http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) ...
(Date:2/6/2012)... shimmer in the light like the scales on ... color-change components of a revolutionary new approach to ... in International Journal of Design Engineering . ... GmbH in Austria are working with Roland Palkovits ... Neustadt, to develop a nanoparticle microfluidic color device ...
(Date:2/6/2012)... Texas, Feb. 6, 2012 Dietary supplements ... government regulations in the United States, according to ... Botanical Council (ABC). The article notes ... granted to the U.S. Food and Drug Administration ... well as other government agencies. (Logo: ...
Breaking Biology Technology:Stevenage Bioscience Catalyst Opens With Exciting Year Ahead 2Stevenage Bioscience Catalyst Opens With Exciting Year Ahead 3Stevenage Bioscience Catalyst Opens With Exciting Year Ahead 4Stevenage Bioscience Catalyst Opens With Exciting Year Ahead 5Stevenage Bioscience Catalyst Opens With Exciting Year Ahead 6Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012 2Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012 3The butterfly effect in nanotech medical diagnostics 2Dietary Supplements Extensively Regulated, Say Authors of New Article 2Dietary Supplements Extensively Regulated, Say Authors of New Article 3Dietary Supplements Extensively Regulated, Say Authors of New Article 4Dietary Supplements Extensively Regulated, Say Authors of New Article 5
... Brookfield-based Fiserv Inc. has unveiled a program of ... financial processing and health-plan administration. , ,Spurred ... healthcare banking is a set of services which ... moving payments between parties in healthcare transactions. , ...
... medical business struggles with the problems of clinical risks and ... through the use of war-game exercises, in which scenarios that ... can be simulated in the course of hours and allow ... they can pose a real threat. , ,While simulations have ...
... Bone Care International Inc. announced on Wednesday that the U.S. ... and Bone Care have signed a definitive agreement for Genzyme ... valued at $33.00 per fully diluted share. The ... shareholders at a meeting on June 30, and other customary ...
Other Biology Technology:Medical simulations identify potential problems before they can pose a real threat 2Medical simulations identify potential problems before they can pose a real threat 3
(Date:2/10/2012)... SAN DIEGO, Feb. 10, 2012  Trovagene, ... transrenal molecular diagnostics, has announced that Stephen ... Mr. Zaniboni,s experience includes ... financing and IPO proceeds.  Mr. Zaniboni previously served as ... company Awarepoint and XIFIN Inc., a provider ...
(Date:2/9/2012)... type 2 diabetes (T2D) has identified new gene ... disease. An international scientific consortium, studying multiethnic populations, ... for developing more effective drugs for T2D. , ... which affects nearly 300 million people worldwide. The ... "Scientists have identified only about 10 percent ...
(Date:2/9/2012)... bacteria infect a human host, cells of various ... address the threat. , In new research appearing ... Nature Immunology , Roy Curtiss, director of the ... Biodesign Institute at Arizona State University, along with ... type of immune response, involving the release of ...
Breaking Biology News(10 mins):Stephen Zaniboni Joins Trovagene, Inc. as Chief Financial Officer 2Stephen Zaniboni Joins Trovagene, Inc. as Chief Financial Officer 3Largest-ever gene study of Type 2 diabetes finds variants across many ethnic groups 2Secrets of immune response illuminated in new study 2Secrets of immune response illuminated in new study 3Secrets of immune response illuminated in new study 4Consumer Group Responds to Governor Schwarzeneggers Incorrect Claims About the Impact of Medical Malpractice Caps 60361 1Consumer Group Responds to Governor Schwarzeneggers Incorrect Claims About the Impact of Medical Malpractice Caps 60361 2Consumer Group Responds to Governor Schwarzeneggers Incorrect Claims About the Impact of Medical Malpractice Caps 60361 3Violence Prevention Advocate Dan Monez Expanding San Diego Company Up North 60358 1Violence Prevention Advocate Dan Monez Expanding San Diego Company Up North 60358 2Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 1Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 2Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 3
... climate change, pollution and human activity. ESA,s ERS and ... region for the last 17 years. These long term ... be key in implementing the newly adopted European Commission ... , The policy highlights new opportunities in the region ...
... levels in fish are prompting widespread consumption advisories and ... eat. Now researchers at North Carolina State University have ... around the country predict which areas are likely to ... that should help officials address public uncertainty by developing ...
... hold a colloquium to examine what lies ahead in ... Leading researchers and students will discuss new tools to ... the perspectives of ecology, paleontology, phylogenetics, and biodiversity informatics ... Sackler Colloquium series, the event will take place at ...
Other Biology News:ESA satellites focusing on the Arctic 2New model predicts hot spots for mercury in fish 2
... Xcise is a powerful technology platform that ... analysis. High quality sample preparation can ... , The Xcise is a powerful technology ... throughput proteome analysis. It combines the functions ...
Extra Large bottle for hybridization 300 x 70mm...
Request Info...
... The Thermo IEC Microtube Rotor is ... have to change rotors. You can ... and PCR tubes. Exclusive polypropylene rotor design ... repeatedly autoclaved. Polypropylene rotors are fully ...
Biology Products: